Igor Nudelman

1.1k total citations
15 papers, 859 citations indexed

About

Igor Nudelman is a scholar working on Molecular Biology, Genetics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Igor Nudelman has authored 15 papers receiving a total of 859 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Genetics and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Igor Nudelman's work include RNA and protein synthesis mechanisms (7 papers), Bacterial Genetics and Biotechnology (5 papers) and CRISPR and Genetic Engineering (3 papers). Igor Nudelman is often cited by papers focused on RNA and protein synthesis mechanisms (7 papers), Bacterial Genetics and Biotechnology (5 papers) and CRISPR and Genetic Engineering (3 papers). Igor Nudelman collaborates with scholars based in Israel, United States and Germany. Igor Nudelman's co-authors include Timor Baasov, Mariana Hainrichson, Valery Belakhov, Tamar Ben‐Yosef, Annie Rebibo-Sabbah, Daniel S. Pilch, Fuquan Chen, Jochen Schacht, Zubair M. Ahmed and Peter Huppke and has published in prestigious journals such as ACS Nano, PLoS ONE and Journal of Controlled Release.

In The Last Decade

Igor Nudelman

15 papers receiving 849 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Igor Nudelman Israel	13	670	172	100	79	76	15	859
Mariana Hainrichson Israel	11	629 0.9×	114 0.7×	39 0.4×	184 2.3×	40 0.5×	12	832
Chunfen Zhang Canada	18	485 0.7×	150 0.9×	24 0.2×	21 0.3×	70 0.9×	56	854
Hannah N. Bell United States	17	453 0.7×	42 0.2×	104 1.0×	33 0.4×	29 0.4×	26	1.0k
Matthew D. Fuller United States	11	404 0.6×	46 0.3×	54 0.5×	42 0.5×	22 0.3×	15	516
Maxim M. Bespalov Finland	15	474 0.7×	73 0.4×	18 0.2×	27 0.3×	13 0.2×	21	1.0k
Go Hirokawa United States	18	1.4k 2.1×	314 1.8×	24 0.2×	20 0.3×	11 0.1×	25	1.7k
Daniel Osorio United States	13	527 0.8×	54 0.3×	25 0.3×	8 0.1×	40 0.5×	30	748
Elizabeth J. White United States	15	792 1.2×	26 0.2×	17 0.2×	13 0.2×	14 0.2×	18	1.0k
Hermann Bihler United States	17	661 1.0×	78 0.5×	277 2.8×	6 0.1×	23 0.3×	23	923
Mingyu Han China	14	229 0.3×	65 0.4×	22 0.2×	15 0.2×	204 2.7×	45	577

Countries citing papers authored by Igor Nudelman

Since Specialization

Citations

This map shows the geographic impact of Igor Nudelman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Igor Nudelman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Igor Nudelman more than expected).

Fields of papers citing papers by Igor Nudelman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Igor Nudelman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Igor Nudelman. The network helps show where Igor Nudelman may publish in the future.

Co-authorship network of co-authors of Igor Nudelman

This figure shows the co-authorship network connecting the top 25 collaborators of Igor Nudelman. A scholar is included among the top collaborators of Igor Nudelman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Igor Nudelman. Igor Nudelman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Nudelman, Igor, Ido Livneh, Madeleine Benguigui, et al.. (2025). Bone Marrow-Targeted Liposomes Loaded with Bortezomib Overcome Multiple Myeloma Resistance. ACS Nano. 19(12). 11684–11701. 4 indexed citations

Korach-Rechtman, Hila, Galoz Kaneti, Igor Nudelman, et al.. (2022). Lung targeted liposomes for treating ARDS. Journal of Controlled Release. 346. 421–433. 58 indexed citations

Rowe, Steven M., Peter A. Sloane, Li Tang, et al.. (2011). Suppression of CFTR premature termination codons and rescue of CFTR protein and function by the synthetic aminoglycoside NB54. Journal of Molecular Medicine. 89(11). 1149–1161. 59 indexed citations

Vecsler, Manuela, Bruria Ben Zeev, Igor Nudelman, et al.. (2011). Ex Vivo Treatment with a Novel Synthetic Aminoglycoside NB54 in Primary Fibroblasts from Rett Syndrome Patients Suppresses MECP2 Nonsense Mutations. PLoS ONE. 6(6). e20733–e20733. 42 indexed citations

Brendel, Cornelia, Valery Belakhov, Hauke Werner, et al.. (2010). Readthrough of nonsense mutations in Rett syndrome: evaluation of novel aminoglycosides and generation of a new mouse model. Journal of Molecular Medicine. 89(4). 389–398. 79 indexed citations

Nudelman, Igor, et al.. (2010). Repairing faulty genes by aminoglycosides: Development of new derivatives of geneticin (G418) with enhanced suppression of diseases-causing nonsense mutations. Bioorganic & Medicinal Chemistry. 18(11). 3735–3746. 103 indexed citations

Pokrovskaya, Varvara, Igor Nudelman, Jeyakumar Kandasamy, & Timor Baasov. (2010). Aminoglycosides. Methods in enzymology on CD-ROM/Methods in enzymology. 478. 437–462. 24 indexed citations

Goldmann, Tobias, Annie Rebibo-Sabbah, Nora Overlack, et al.. (2010). Beneficial Read-Through of aUSH1CNonsense Mutation by Designed Aminoglycoside NB30 in the Retina. Investigative Ophthalmology & Visual Science. 51(12). 6671–6671. 48 indexed citations

Nudelman, Igor, Annie Rebibo-Sabbah, Valery Belakhov, et al.. (2009). Development of Novel Aminoglycoside (NB54) with Reduced Toxicity and Enhanced Suppression of Disease-Causing Premature Stop Mutations. Journal of Medicinal Chemistry. 52(9). 2836–2845. 153 indexed citations

10.

Nudelman, Igor, et al.. (2008). Combined Chemical‐Enzymatic Assembly of Aminoglycoside Derivatives with N‐1‐AHB Side Chain. Advanced Synthesis & Catalysis. 350(11-12). 1682–1688. 6 indexed citations

11.

Kondo, Jiro, Mariana Hainrichson, Igor Nudelman, et al.. (2007). Differential Selectivity of Natural and Synthetic Aminoglycosides towards the Eukaryotic and Prokaryotic Decoding A Sites. ChemBioChem. 8(14). 1700–1709. 50 indexed citations

12.

Hainrichson, Mariana, Igor Nudelman, & Timor Baasov. (2007). Designer aminoglycosides: the race to develop improved antibiotics and compounds for the treatment of human genetic diseases. Organic & Biomolecular Chemistry. 6(2). 227–239. 92 indexed citations

13.

Rebibo-Sabbah, Annie, Igor Nudelman, Zubair M. Ahmed, Timor Baasov, & Tamar Ben‐Yosef. (2007). In vitro and ex vivo suppression by aminoglycosides of PCDH15 nonsense mutations underlying type 1 Usher syndrome. Human Genetics. 122(3-4). 373–381. 61 indexed citations

14.

Hainrichson, Mariana, et al.. (2007). Overexpression and Initial Characterization of the Chromosomal Aminoglycoside 3′- O -Phosphotransferase APH(3′)-IIb from Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 51(2). 774–776. 17 indexed citations

15.

Nudelman, Igor, et al.. (2006). Redesign of aminoglycosides for treatment of human genetic diseases caused by premature stop mutations. Bioorganic & Medicinal Chemistry Letters. 16(24). 6310–6315. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact